This is a study to compare the effectiveness of a drug called Corlux (mifepristone) to a placebo in adults who suffer from psychotic symptoms associated with major depression. This national study is currently recruiting adults ages 22 to 75 years old who have major depressive disorder with psychotic features.
Read moreMajor depression is the most severe form of depression and involves most or all of the symptoms associated with clinical depression.... Read more »
A new study in the STAR*D depression trial has found that two different drug regimens are effective in treating major depression. Patients in the... Read more »
This is a study to determine the safety and effectiveness of a new medication, Corlux (mifepristone), in patients who have been diagnosed with... Read more »
The FDA has approved EMSAM (selegiline), a transdermal patch, for the treatment of major depression. Selegeline is a MAOI originally used to treat... Read more »
Source: Harvard Decision Guide
When To Call A Professional Depression is a painful and potentially dangerous illness, so you should contact a health care professional if you have... Read more »
This is a study to assess the safety and effectiveness of Valdoxan in patients with major depressive disorder. This national study is currently... Read more »